| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b85b68ef371ec9c8ce0c97811ea032a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2006-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f978f2a74b66e4607c1c50c89ce26c99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dde0b9452d3d72a93867ea8a6c360491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35187d62ddc0a6b4b46d7c5e12d3979c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e07576ad4d45b2f273c9795451ef0c24 |
| publicationDate |
2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0615466-A2 |
| titleOfInvention |
tumor-associated peptides that bind to human leukocyte antigen (hla) class i or ii molecules and the corresponding anticancer vaccine |
| abstract |
PEPTIDES ASSOCIATED WITH TUMORS CONNECTING TO CLASS I OR II MOLECULES OF THE HUMAN ANTIGEN LEUKOCITARY (HLA) AND CORRESPONDING ANTI-CANCER VACCINE. The present invention relates to immunotherapeutic methods and to molecules and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated T-helper peptide epitopes, alone or in combination with other tumor-associated peptides, which serve as active pharmaceutical ingredients in antitumor immune response-stimulating vaccine compositions. In particular, the present invention relates to two novel peptide sequences derived from HLA class II molecules from human tumor cell lines that can be used in vaccine compositions to elicit anti-tumor immune responses. |
| priorityDate |
2005-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |